SCHILKE TOBIN (CFO) received a stock award from REVANCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2025ACC: 0001479290-25-000005
Officer· CFO
Since Nov 2018
+1K
Net shares
Net buyer
$2.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
$2.18
Trade value
$2.18K
% of position
0.5%
12/31/2024
193.67K→194.67K
Total
Net shares
+1K
Net value
$2.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2024 | A · Award | +1K | $2.18 | $2.18K | 0.5% | 193.67K | 194.67K |
| Total | +1K | $2.18K | ||||||
Derivative Transactions0
No derivative transactions reported